InMode Introduces Morpheus8 Body Multi-pulse Burst Technology

Rhea-AI Summary

InMode Ltd. (Nasdaq: INMD) has launched the Morpheus8 Body Multi-pulse Burst Radiofrequency Technology, enhancing the previously released Morpheus8 Body Subdermal Adipose Remodeling Device. This innovative technology employs a three-level sequential RF energy deployment, which reduces treatment times and minimizes skin injury. InMode's President highlighted that this launch solidifies the company’s leadership in fractional treatments. The Morpheus8 Burst technology is based on the Vulcanization Process, aiming to improve skin elasticity and strength.

Positive

• Launch of Morpheus8 Body Multi-pulse Burst Technology creates a competitive edge in fractional treatments.
• The technology significantly reduces treatment times and minimizes skin injury, enhancing patient experience.
• Solidifies InMode's position as a leader in the fractional medical aesthetic market.

Negative

• None.

LAKE FOREST, Calif., Oct. 20, 2020 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, is pleased to introduce to the market the Morpheus8 Body Multi-pulse Burst Radiofrequency Vulcanization Technology.

Expanding on the recent launch of the Morpheus8 Body Subdermal Adipose Remodeling Device (SARD), the first and only FDA cleared technology to penetrate tissue with a thermal profile of 8mm, comes Morpheus8 Body Burst Technology.  This groundbreaking, industry-first, fractional technology automatically deploys bipolar RF energy to multi-level treatment depths in a single cycle.  The ability to target tissue sequentially at three levels, in millisecond intervals, allows for a significant reduction in treatment times, minimizes skin injury, increases treatment uniformity, and enables customized full body fractional procedures beyond anything previously available.

"Morpheus8 Burst RF technology was predicated on the principles of the Vulcanization Process for cross linking rubber molecules to improve elasticity and tensile strength," said Dr. Spero Theodorou, InMode Chief Medical Officer. "Burst mode mediated RF Vulcanization involves a 3-step process, forming cross links between long collagen fiber molecules in a stratified depth range, to brace the Fibro Septal Network (FSN) and ultimately strengthen the overall skin-adipose scaffold. We are very proud to bring this unprecedented, highly efficacious modality to RF fractional treatments."

InMode President of North America, Shakil Lakhani, commented, "With the recent launch of Morpheus8 Body, InMode pioneered full body fractional treatments. The subsequent commercialization of Morpheus8 Burst with multi-level energy deployment unequivocally solidifies InMode as the fractional market leader. Our robust innovation pipeline continues to redefine the medical aesthetics industry and further differentiates InMode as the frontrunner for delivering leading-edge treatment solutions."

About InMode 

InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radio-frequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically-accepted minimally-invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. 

For more information about InMode, please visit www.inmodemd.com.

Press Contact:
Behrman Communications
Amanda Reinstein
areinstein@behrmanpr.com

Investor Contact:
MS-IR LLC
Miri Segal – Scharia
ir@inmodemd.com
917-607-8654

View original content to download multimedia:http://www.prnewswire.com/news-releases/inmode-introduces-morpheus8-body-multi-pulse-burst-technology-301155418.html

SOURCE InMode Ltd.

FAQ

What is the new technology introduced by InMode?

InMode introduced the Morpheus8 Body Multi-pulse Burst Radiofrequency Technology, which enhances their existing fractional treatments.

When was the Morpheus8 Body Burst Technology launched?

The Morpheus8 Body Burst Technology was launched on October 20, 2020.

How does Morpheus8 Burst Technology improve treatments?

It allows for multi-level RF energy deployment in a single cycle, reducing treatment times and minimizing skin injury.

What is the market significance of Morpheus8 Burst Technology?

This product solidifies InMode's leadership in the fractional market, offering unprecedented treatment capabilities.

What is the ticker symbol for InMode?

The ticker symbol for InMode is INMD.